Finance

Lists
Why is NZIA down 2.80%?
Dive Deeper
NZIA:IDX
Nusantara Almazia Tbk PT
IDR 139.00
-2.80%
(-4.00) 1D
Oct 13, 4:12:01 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for NZIA...
Open
IDR 143
High
IDR 144
Low
IDR 131
Mkt. cap
305.46B
Avg. vol.
37.68M
Volume
1.76M
52-wk high
IDR 316
52-wk low
IDR 84
EPS
-IDR 6
Shares outstanding
2.20B
No. of employees
41
Open
IDR 143
High
IDR 144
Low
IDR 131
Mkt. cap
305.46B
Avg. vol.
37.68M
Volume
1.76M
52-wk high
IDR 316
52-wk low
IDR 84
EPS
-IDR 6
Shares outstanding
2.20B
No. of employees
41
News stories
From web sources and news partners
About Nusantara Almazia Tbk PT
CEO-
Employees41
Founded2007
Headquarters-
Sector-
Websitenusantara-almazia.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.70B
8.61B
4.36B
26.13B
Cost of goods sold
4.18B
6.65B
3.07B
16.12B
Cost of revenue
4.18B
6.65B
3.07B
16.12B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08B
7.93B
3.99B
7.36B
Operating expense
4.43B
7.99B
4.16B
7.83B
Total operating expenses
8.60B
14.64B
7.23B
23.95B
Operating income
-1.90B
-6.03B
-2.87B
2.19B
Other non operating income
-
-296.67M
-
-
EBT including unusual items
-2.88B
-7.15B
-3.72B
1.28B
EBT excluding unusual items
-2.88B
-7.15B
-3.72B
1.28B
Income tax expense
74.32M
110.10M
38.33M
342.86M
Effective tax rate
-2.58%
-1.54%
-1.03%
26.72%
Other operating expenses
342.57M
54.76M
165.45M
472.91M
Net income
-2.86B
-6.73B
-3.39B
-579.61M
Net profit margin
-42.70%
-78.10%
-77.84%
-2.22%
Earnings per share
-
-
-
-
Interest and investment income
8.47M
4.60M
3.21M
4.33M
Interest expense
-988.32M
-824.75M
-855.46M
-907.92M
Net interest expenses
-979.85M
-820.15M
-852.25M
-903.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.68B
-5.91B
-2.65B
2.40B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps